About Klinische-Forschung Hannover Mitte
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merz Pharmaceuticals GmbH
1
Shire
1
Valbiotis
1
Vanda Pharmaceuticals
1
Clinical Trials at Klinische-Forschung Hannover Mitte
During the past decade, Klinische-Forschung Hannover Mitte conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
2010-08-01
2012-11-01
Completed
136
Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
2010-11-01
2011-09-01
Completed
299
Open Label Extension in Adults With Binge Eating Disorder (BED)
2012-08-21
2014-10-21
Completed
604
Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)
2020-07-08
2023-04-30
Active, not recruiting
600
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinische-Forschung Hannover Mitte"
#1 collaborator was "Biofortis Mérieux NutriSciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinische-Forschung Hannover Mitte
According to Clinical.Site data, the most researched conditions in "Klinische-Forschung Hannover Mitte" are
"Binge Eating Disorder" (1 trials), "Diabetes type2" (1 trials), "Dysglycemia" (1 trials), "Memory Disorder" (1 trials) and "Memory, Concentration or Attention Problems" (1 trials). Many other conditions were trialed in "Klinische-Forschung Hannover Mitte" in a lesser frequency.
Clinical Trials Intervention Types at Klinische-Forschung Hannover Mitte
Most popular intervention types in "Klinische-Forschung Hannover Mitte" are "Drug" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Lisdexamfetamine dimesylate" (1 trials), "Memantine" (1 trials), "Placebo 3 intakes per day" (1 trials) and "TOTUM-63 2 intakes per day" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinische-Forschung Hannover Mitte
The vast majority of trials in "Klinische-Forschung Hannover Mitte" are
4 trials for "All" genders.
Clinical Trials Status at Klinische-Forschung Hannover Mitte
Currently, there are NaN active trials in "Klinische-Forschung Hannover Mitte".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinische-Forschung Hannover Mitte,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinische-Forschung Hannover Mitte, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".